Research On The Impact Of Enterprise Income Tax Preference On Innovation Of Biomedical Enterprises

With the rise of the third scientific and technological revolution and the continuous improvement of the level of science and technology,scientific and technological innovation has become the core force to promote the sustainable development of the world economy.Nowadays,science and technology are leading the trend of world economic development.As the primary productive force,science and technology are affecting every aspect of human society.Among them,the high-tech and new biomedical industry enterprises play a very important role.The biomedical industry plays an important role in people's lives in both developed and developing countries.As one of the main high-tech industries in China,the biomedical industry has obvious "positive externalities" characteristics.At the same time,it is sensitive to the preferential policies of enterprise income tax.Because tax has the function of regulating economy and encouraging enterprises to innovate,the government can adopt preferential tax policies to impel biomedical enterprises to carry out innovative activities.A comprehensive and in-depth study of the impact of preferential corporate income tax policies on incentive effect of biomedical enterprises is conducive to providing substantive suggestions for the government to formulate policies and guide enterprises to apply policies.Based on the theoretical basis of tax preferential policies to stimulate technological innovation of enterprises,starting from the current situation of biomedical enterprises in China and preferential policies of enterprise income tax,in view of the incentive effect of preferential tax policies on biomedical industry,this paper explores innovation input and innovation output in order to provide targeted suggestions for the further improvement of tax preferential policies.To this end,this paper starts from six aspects.Firstly,the first part of this paper briefly presents the introduction,including the research context,importance,contents,methods,and so on.At the same time,this part of this paper also expounds the possible innovations.Then,the second part of this paper,starting from the externality theory and uncertainty theory,elaborates the necessity of tax preferential policies to stimulate innovation of biomedical enterprises,and analyses the mechanism of tax preferential policies to stimulate innovation of biomedical enterprises,thus laying the theoretical foundation for the following analysis.Next,the third part of this paper,through the relevant data and charts,briefly introduces the development status of China's biomedical industry,the applicable preferential policies of enterprise income tax,and analyzes the six major problems of preferential policies.Next,the fourth part of this paper selects 80 biomedical enterprises from Shanghai and Shenzhen Stock Exchanges from 2012 to 2017 as samples and establishes a two-model regression analysis of innovation input and innovation output.Moreover,this part makes an empirical summary of the results of regression analysis.At last,connecting with the current problems and other conclusions,the fifth part of this paper,aiming at the problems existing in the current preferential corporate income tax policies applicable to biomedical enterprises in China,puts forward suggestions for improvement from both government and enterprises.In the sixth part of this article,based on the full text,this part summarizes the whole article,points out the shortcomings in the writing process and makes a prospect for the improvement of the follow-up research.